{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:56:33Z","timestamp":1792900593166,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.beem.2011.10.003","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T10:31:30Z","timestamp":1337769090000},"page":"281-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Immunopathogenesis of Graves\u2019 ophthalmopathy: The role of the TSH receptor"],"prefix":"10.1016","volume":"26","author":[{"given":"Seethalakshmi","family":"Iyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2011.10.003_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.10.003_bib2","first-page":"1070","article-title":"Cell-mediated or humoral immunity in Graves\u2019 ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue","volume":"78","author":"McLachlan","year":"1994","journal-title":"Journal of Clinical Endocrinology Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/edrv-10-3-366","article-title":"Connective tissue, glycosaminoglycans, and diseases of the thyroid","volume":"10","author":"Smith","year":"1989","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib4","first-page":"568","article-title":"Dysthyroid optic neuropathy without extraocular muscle involvement","volume":"20","author":"Anderson","year":"1989","journal-title":"Ophthalmic Surgery"},{"key":"10.1016\/j.beem.2011.10.003_bib5","first-page":"651","article-title":"Ophthalmopathy of Graves\u2019 disease: computerized volume measurements of the orbital fat and muscle","volume":"7","author":"Forbes","year":"1986","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.beem.2011.10.003_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2010.04.004","article-title":"Do subtypes of Graves\u2019 orbitopathy exist?","volume":"118","author":"Regensburg","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.beem.2011.10.003_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF03350193","article-title":"Temporal relationship between onset of Graves\u2019 ophthalmopathy and onset of thyroidal Graves\u2019 disease","volume":"11","author":"Wiersinga","year":"1988","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.10.003_bib8","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves\u2019 ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.beem.2011.10.003_bib9","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1172\/JCI117289","article-title":"Retrobulbar T cells from patients with Graves\u2019 ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts","volume":"93","author":"Grubeck-Loebenstein","year":"1994","journal-title":"Journal of Clinical Investigation"},{"issue":"Suppl. 15","key":"10.1016\/j.beem.2011.10.003_bib10","first-page":"S77","article-title":"TSH receptor in endocrine autoimmunity","volume":"14","author":"Otto","year":"1996","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.beem.2011.10.003_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bjo.84.5.517","article-title":"T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy","volume":"84","author":"Pappa","year":"2000","journal-title":"British Journal of Ophthalmology"},{"key":"10.1016\/j.beem.2011.10.003_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.beem.2011.10.003_bib15","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2008.0255","article-title":"Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts from patients with Graves\u2019 ophthalmopathy","author":"Khoo","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib16","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","article-title":"Graves\u2019 ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels","volume":"10","author":"Khoo","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03192.x","article-title":"Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves\u2019 hyperthyroidism: a prospective study","volume":"69","author":"Vos","year":"2008","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.10.003_bib21","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.1998.8.193","article-title":"Thyrotropin receptor expression in cultured Graves\u2019 orbital preadipocyte fibroblasts is stimulated by thyrotropin","volume":"8","author":"Bahn","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2011.10.003_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0029-1211178","article-title":"Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves\u2019 ophthalmopathy","volume":"100","author":"Heufelder","year":"1992","journal-title":"Experimental and Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose thyrotrophin receptor expression is elevated in Graves\u2019 and thyroid eye diseases ex\u00a0vivo and indicates adipogenesis in progress in\u00a0vivo","volume":"30","author":"Starkey","year":"2003","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib26","first-page":"998","article-title":"Thyrotropin receptor expression in Graves\u2019 orbital adipose\/connective tissues: potential autoantigen in Graves\u2019 ophthalmopathy","volume":"83","author":"Bahn","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib28","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor","volume":"84","author":"Valyasevi","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.00031.2001","article-title":"Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships","volume":"82","author":"Szkudlinski","year":"2002","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0014-5793(97)00532-2","article-title":"Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain","volume":"409","author":"Duprez","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1016\/j.beem.2011.10.003_bib31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2011.10.003_bib32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/en.2002-0069","article-title":"The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors","volume":"144","author":"Schwarz-Lauer","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib33","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/me.2010-0001","article-title":"Subunit interactions influence TSHR multimerization","volume":"24","author":"Latif","year":"2010","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(95)01384-9","article-title":"Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone\/chorionic gonadotropin receptors","volume":"378","author":"Cetani","year":"1996","journal-title":"FEBS Letters"},{"key":"10.1016\/j.beem.2011.10.003_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01076769","article-title":"Signal transduction through the cAMP-dependent protein kinase","volume":"127\u2013128","author":"Meinkoth","year":"1993","journal-title":"Molecular and Cellular Biochemistry [Review]"},{"key":"10.1016\/j.beem.2011.10.003_bib37","first-page":"596","article-title":"The thyrotropin receptor and the regulation of thyrocyte function and growth","volume":"13","author":"Vassart","year":"1992","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/thy.2007.0170","article-title":"The thyrotropin receptor in Graves\u2019 disease","volume":"17","author":"Rapoport","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib40","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1210\/en.2010-0424","article-title":"Neutral antibodies to the TSH receptor are present in Graves\u2019 disease and regulate selective signaling cascades","volume":"151","author":"Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib41","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157: pathophysiology of Graves\u2019 ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism [Review]"},{"key":"10.1016\/j.beem.2011.10.003_bib42","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1210\/jc.2004-2239","article-title":"Gene expression profiling of orbital adipose tissue from patients with Graves\u2019 ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis","volume":"90","author":"Kumar","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib43","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/jc.2004-2275","article-title":"Overexpression of immediate early genes in active Graves\u2019 ophthalmopathy","volume":"90","author":"Lantz","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy","volume":"46","author":"Kumar","year":"2011","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib45","first-page":"59","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid [Research Support, N.I.H., Extramural]"},{"key":"10.1016\/j.beem.2011.10.003_bib46","doi-asserted-by":"crossref","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","article-title":"Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction","volume":"284","author":"Zhang","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.10.003_bib47","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.06-0596","article-title":"Biological effects of thyrotropin receptor activation on human orbital preadipocytes","volume":"47","author":"Zhang","year":"2006","journal-title":"Investigative Ophthalmology and Visual Sciences"},{"key":"10.1016\/j.beem.2011.10.003_bib48","doi-asserted-by":"crossref","first-page":"25687","DOI":"10.1074\/jbc.M700773200","article-title":"Involvement of hyaluronan in regulation of fibroblast phenotype","volume":"282","author":"Meran","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.10.003_bib49","first-page":"4079","article-title":"Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"84","author":"Kaback","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S1357-2725(03)00048-7","article-title":"The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers","volume":"35","author":"Monslow","year":"2003","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.beem.2011.10.003_bib51","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1074\/jbc.M510680200","article-title":"A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation","volume":"281","author":"Lewthwaite","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.10.003_bib52","doi-asserted-by":"crossref","first-page":"22901","DOI":"10.1074\/jbc.M109.088435","article-title":"Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt","volume":"285","author":"Kultti","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.10.003_bib53","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/thy.2009.0447","article-title":"Effects of thyrotropin and thyrotropin-receptor-stimulating Graves\u2019 disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves\u2019 ophthalmopathy patients","volume":"20","author":"van Zeijl","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/thy.2010.0123","article-title":"Thyrotropin receptor-stimulating Graves\u2019 disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves\u2019 ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways","volume":"21","author":"van Zeijl","year":"2011","journal-title":"Thyroid"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2011.10.003_bib56","article-title":"IGF-1 receptor blockade inhibits hyaluronan synthesis induced by a stimulatory thyrotropin receptor antibody in Graves\u2019 orbital fibroblasts","volume":"21","author":"Kumar","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.10.003_bib57","doi-asserted-by":"crossref","first-page":"16317","DOI":"10.1074\/jbc.M109.005710","article-title":"The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor","volume":"284","author":"Mueller","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.10.003_bib58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem-54-5-1059","article-title":"Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue","volume":"54","author":"Rapoport","year":"1982","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.beem.2011.10.003_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocrine Reviews"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2011.10.003_bib61","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1677\/erc.1.01280","article-title":"IGF1R signaling and its inhibition","volume":"13","author":"Riedemann","year":"2006","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/j.beem.2011.10.003_bib62","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.ijo.0802961","article-title":"Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture","volume":"29","author":"Aubin","year":"2005","journal-title":"International Journal of Obesity (London)"},{"key":"10.1016\/j.beem.2011.10.003_bib63","article-title":"Detection of autoantibodies against the insulin-like growth factor-1 receptor in patients with Graves\u2019 orbitopathy by luminescent immunoprecipitation analysis","volume":"39","author":"Minish","year":"2010"},{"key":"10.1016\/j.beem.2011.10.003_bib64","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.beem.2011.10.003_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1749-6632.1986.tb20865.x","article-title":"Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves\u2019 disease","volume":"475","author":"Kohn","year":"1986","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.beem.2011.10.003_bib66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves\u2019-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib67","article-title":"IGF-1 receptor blockade inhibits Akt phosphorylation induced by a stimulatory thyrotropin receptor antibody in Graves\u2019 orbital preadipocyte fibroblasts","volume":"31","author":"Kumar","year":"2010"},{"key":"10.1016\/j.beem.2011.10.003_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08977190410001700998","article-title":"Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor","volume":"22","author":"Adams","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.beem.2011.10.003_bib69","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jc.2011-0307","article-title":"Autoimmunity in Graves\u2019 ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?","volume":"96","author":"Wiersinga","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.10.003_bib70","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1210\/en.2008-0836","article-title":"A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism","volume":"149","author":"Neumann","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.10.003_bib71","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2010-1935","article-title":"A new small-molecule antagonist inhibits Graves\u2019 disease antibody activation of the TSH receptor","volume":"96","author":"Neumann","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:44:56Z","timestamp":1761497096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X11001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521690X11001308"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2011.10.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopathogenesis of Graves\u2019 ophthalmopathy: The role of the TSH receptor","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}